Abstract
As allogeneic bone marrow transplantation (BMT) is a procedure with a higher risk of morbidity and mortality in older patients, many institutions place a limit of 50 to 55 years for allogeneic BMT. Consequently, older patients may not be offered potentially curative treatment for otherwise poor prognosis diseases such as AML or myelodysplastic syndrome. We compared the outcome of 59 patients aged over 50, 124 aged 40–50, and 253 aged 18–39 years who underwent allogeneic BMT in our institution between August 1987 and April 1996. Our results show little influence of age on outcome when comparing patients over 50 years with patients 40–50 years. Apart from an initial higher transplant mortality rate, overall survival was not significantly different between the three age groups. The 1-year and 2-year overall survival rates were 57% and 48%, 57% and 48%, and 62% and 58% for the >50 years, 40–50 years, and <40 years patients, respectively. the incidence of gvhd was also comparable. we conclude that allogeneic bmt can be performed in selected patients over the age of 50 years with acceptable morbidity and mortality and that older patients should not be denied this treatment based on age alone.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Du, W., Dansey, R., Abella, E. et al. Successful allogeneic bone marrow transplantation in selected patients over 50 years of age – a single institution’s experience. Bone Marrow Transplant 21, 1043–1047 (1998). https://doi.org/10.1038/sj.bmt.1701210
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701210
Keywords
This article is cited by
-
The evolution of hematopoietic SCT in myelodysplastic syndrome
Bone Marrow Transplantation (2009)
-
Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age
Annals of Hematology (2009)
-
Are predictive factors clinically useful in bone marrow transplantation?
Bone Marrow Transplantation (2003)
-
Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged ≥50 years compared to younger adults with low-risk disease
Bone Marrow Transplantation (2003)
-
Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens
Bone Marrow Transplantation (2003)